Integrating Services Research into CTN Clinical Trials: The Devil is in the Details - PowerPoint PPT Presentation

About This Presentation
Title:

Integrating Services Research into CTN Clinical Trials: The Devil is in the Details

Description:

Integrating Services Research into CTN Clinical Trials: The Devil is in the Details ... Opportunities to participate as new clinical trials are planned and conducted ... – PowerPoint PPT presentation

Number of Views:30
Avg rating:3.0/5.0
Slides: 14
Provided by: Harol88
Learn more at: https://ctnlibrary.org
Category:

less

Transcript and Presenter's Notes

Title: Integrating Services Research into CTN Clinical Trials: The Devil is in the Details


1
Integrating Services Research into CTN Clinical
TrialsThe Devil is in the Details
Synergy
  • Harold I Perl, PhD
  • Center for the Clinical Trials Network
  • National Institute on Drug Abuse

Addiction Health Services Research
Conference October 16, 2007 Athens, GA
2
Why Do HSR in CTN?
  • CTN blends skill and experience of two key groups
    of experts
  • community-based treatment providers
  • academic researchers
  • Diverse and extensive network interested in
    developing and participating in research on
    critical public health issues
  • Incorporating HSR into existing clinical trials
    can be resource-efficient

3
Why Do HSR in CTN Now?
  • Blue Ribbon Task Force on HSR in NIDA
  • Recommended closer collaboration with CTN
  • DESPR/SRB enthusiastic to support
  • Supplements to collect baseline/pilot data for
    future R01 applications
  • Current cadre of CCTN staff with expertise,
    experience, and interest in HSR
  • Opportunities to participate as new clinical
    trials are planned and conducted

4
Bringing HSR into a Clinical Trial Already
In-the-Field
  • POATS Prescription Opioid Addiction Treatment
    Study
  • 2 medication management models of varying length,
    complexity, and expense
  • Twice-weekly individual drug counseling added to
    standard medical management
  • 2-Phase design
  • Initial 4-week treatment with taper
  • 12-week stabilization program plus 4-week taper

5
POATS - CE
  • Collect data to calculate the incremental
    cost-effectiveness ratio of enhanced treatment
    compared with standard
  • Cost estimates comprehensive in scope including
  • Facility/program level
  • Treatment staff level
  • Participant level
  • Follow-on R01 application expected

6
POATS - CE
  • Protocol lead team very interested in cost
    effectiveness
  • Key part of recent competing continuation
    application for Node
  • NIDA protocol coordinator also interested in cost
    effectiveness
  • Existing relationship between protocol lead team
    and Brandeis team

7
POATS - CE
  • Expertise and enthusiasm of key players essential
    to making this work
  • Created liaisons at staff level as well as study
    managers
  • Desired assessment package cut down to fit
    reality
  • Approached CTPs already recruiting participants
    and those about to start
  • Small supplement budget required innovative ways
    provide incentives to CTPs
  • Involved CTN data and clinical coordinating
    centers
  • Shared vision did not guarantee shared
    understanding between teams -- needed flexibility
    and realistic expectations from all

8
Bringing HSR into a Clinical Trial During Early
Planning
  • HIV/AIDS Rapid Testing protocol
  • Studying impact of on-site rapid testing,
    HIV-status counseling, or referral to off-site
    testing in drug treatment programs
  • Development team sees it as promising vehicle for
    cost-effectiveness analyses
  • Protocol design still in initial phases
  • Actual integration of HSR as yet unclear

9
Bringing HSR into a Clinical Trial in Advanced
Development
  • STAGE-12
  • Combined group/individual treatment for stimulant
    abusers to facilitate engagement in 12-step
    groups
  • Protocol lead team approached by members of CTN
    HSR Special Interest Group
  • STAGE-12 leaders interested in questions of
    implementation and sustainability
  • NIDA protocol coordinator HSR-experienced

10
STAGE-12 - HSR
  • Existing relationship among key players
  • HSR team already part of CTN family
  • HSR investigators invited to participate in
    weekly protocol development calls
  • Direct negotiations with CTN Data and Clinical
    Coordinating Centers
  • Contributed to design of main study as well as
    HSR component

11
STAGE-12 - HSR
  • Examining organizational and counselor variables
    that may affect implementation
  • Monitoring impact on sustainability in CTPs
    following clinical trial completion
  • Collecting baseline data prior to STAGE-12 trial
    initiation
  • Developing future R01 application to
  • conduct secondary analyses
  • evaluate implementation and fidelity of
    STAGE-12 intervention during and after trial

12
STAGE-12 - HSR
  • Integrating HSR into main STAGE-12 trial
  • Extensive participation of HSR team in planning
    process
  • Overlap of assessment packages allowed
    streamlining in data collection process
  • Alignment of informed consent across studies
  • HSR team collecting counselor-level data to be
    used by main trial
  • STAGE-12 trial providing treatment tapes to HSR
    team for fidelity analyses
  • Full integration and enthusiastic cooperation
    does not guarantee smooth implementation!

13
How You Can Join the Fun
  • Contact SRB staff to discuss options for
    collaborating with current or future CTN trial
  • Apply for RPG funding under existing FOA
  • Health Services Research on Practice Improvement
    Utilizing Community Treatment Programs within the
    National Drug Abuse Clinical Trials Network (CTN)
  • Dissemination and Implementation Research in
    Health
  • Download and analyze public use datasets from CTN
    data share website
  • www.ctndatashare.org
  • 10 datasets currently available
  • More to follow as completed
Write a Comment
User Comments (0)
About PowerShow.com